Bellicum Pharma (BLCM) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Bellicum Pharma (BLCM) Tops Q4 EPS by 8c

Bellicum Pharmaceuticals (BLCM) PT Lowered to $25 at Citi Following Rimiducid Activation Switch

March 15, 2018 6:58 AM EDT

Citi lowered its price target on Bellicum Pharmaceuticals (NASDAQ: BLCM) to $25.00 (from $27.00) while maintaining a Buy rating following the company's announced details of the first patient to receive the Rimiducid activation switch. The company is still investigating what happened to the cells, and noted... More